Plain-English translation of NCT05704062 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether advanced MRI scans can better predict how well a patient will respond to chemotherapy for breast cancer. Researchers want to see if these special imaging techniques can identify which patients are responding to treatment earlier and more accurately than traditional tumor size measurements. The study will compare these new imaging methods to standard approaches used today.
Currently, doctors mainly use tumor size measurements to see if chemotherapy is working, but this can take weeks or months to show results. This trial aims to find faster, more accurate ways to predict which patients will benefit from the treatment so doctors can make better decisions about care earlier in the process.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have four MRI scans: one before starting chemotherapy, one after your first treatment cycle, one at the midpoint of your treatment, and one after you finish chemotherapy. Each scan takes about 45 minutes and uses special imaging techniques to measure how your tumor is responding to treatment. These scans will be compared to your surgery results later to see how accurate the imaging predictions were.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
United States